secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0001193125-24-039387
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm regains Nasdaq minimum bid price compliance
------------------------------------------------------

- Nasdaq confirmed Karyopharm regained compliance with Bid Price Rule on Feb 16, 2024.
- Company met $1.00 minimum closing bid for 10 consecutive business days through Feb 15, 2024.
- Non-compliance was first disclosed on Dec 12, 2023; this resolves the listing deficiency.
- No effect on business operations or financial condition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000119312524039387/0001193125-24-039387-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000119312524039387/d774101d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-039387

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer